510(k) Report

510(k) · Cleared

Cleared

Synthes (Usa) Chronos

K041350510(k) TraditionalCleared Jul 8, 200449-day reviewClass II21 CFR 882.5300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Synthes (Usa) · GXP Methyl Methacrylate For Cranioplasty

Cleared on Jul 8, 2004 after a 49-day review. The FDA summary names its predicate without a number. 40 later devices descend from it.

Decided
Jul 8, 2004
Review
49 days
Class
Class II
Product code
GXP
Recalls
None
Predicates
0

40 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2013: 1 descendant cleared2008: 1 descendant cleared2009: 2 descendants cleared2014: 1 descendant cleared2018: 4 descendants cleared2010: 1 descendant cleared2019: 2 descendants cleared2021: 7 descendants cleared2026: 4 descendants cleared2023: 4 descendants cleared2022: 4 descendants cleared2025: 4 descendants cleared2024: 4 descendants cleared200020052010201520202025
  1. This deviceK041350 Synthes (Usa) ChronosSynthes (Usa) · 2004
  2. Descendant · cites it directly · 38 of its ownK063422 BioaggregateInnovative Bioceramix, Inc. · 2006
  3. Descendant · 2 generations on · 37 of its ownK080917 Iroot SPInnovative Bioceramix, Inc. · 2008
  4. Descendant · 2 generations on · 12 of its ownK082943 Iroot BP, Model Irbp 4609Innovative Bioceramix, Inc. · 2009
  5. Descendant · 3 generations on · 8 of its ownK170175 Endoseal MtaMaruchi · 2018
  6. Descendant · 2 generations on · 7 of its ownK092715 Iroot BP PlusInnovative Bioceramix, Inc. · 2009

Showing 5 of 40 descendants. See all descendants

Descendants cleared per year

2006: 12008: 12009: 22010: 12013: 12014: 12018: 42019: 22021: 72022: 42023: 42024: 42025: 42026: 4
2006high 7 (2021) · low 0 (2007)2026

Most influential descendants

Showing 5 of 40 · See all
  • K063422BioaggregateInnovative Bioceramix, Inc. · 2006 · cites it directly38descendants
  • K080917Iroot SPInnovative Bioceramix, Inc. · 2008 · 2 generations on37descendants
  • K082943Iroot BP, Model Irbp 4609Innovative Bioceramix, Inc. · 2009 · 2 generations on12descendants
  • K170175Endoseal MtaMaruchi · 2018 · 3 generations on8descendants
  • K092715Iroot BP PlusInnovative Bioceramix, Inc. · 2009 · 2 generations on7descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K041350Synthes (Usa) ChronosSynthes (Usa)2004—
+1K063422BioaggregateInnovative Bioceramix, Inc.2006—
+2K080917Iroot SPInnovative Bioceramix, Inc.2008—
+2K082943Iroot BP, Model Irbp 4609Innovative Bioceramix, Inc.2009—
+3K170175Endoseal MtaMaruchi2018—
+2K092715Iroot BP PlusInnovative Bioceramix, Inc.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200810
200920
201010
201310
201410
201840
201920
202170
202240
202340
202440
202540
202640
FIG. 1 — Lineage of K041350, 2004–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXP device

  1. #1 K241027 Permatage Settable Bone Puttyscore 16.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Norian Cranial Repair System (CRS) Bone Cement
Named without a submission number
—
*—Etex al-BSM Bone Substitute Material for Cranioplasty
Named without a submission number
—

What descends from it? (40)

See all 40

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K063422BioaggregateInnovative Bioceramix, Inc.200638
K123633TRS Cranial Bone Void Filler (TRS C-BVF)Tissue Regeneration Systems, Inc.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K063422 (Innovative Bioceramix, Inc., 2006) has gone furthest, with 38 descendants of its own.

How does its category compare?

All GXP devices

GXP Methyl Methacrylate For Cranioplasty: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GXP

4so far in 2026, the most since 2007

2007: 32009: 12010: 12015: 12017: 12019: 12023: 22024: 22026 (partial year): 4
2007high 4 (2026) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXP

87in 2007

2007: 87 days median2026 (partial year): 85 days median
2007high 87 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXP

2in 2019

2009: 12011: 12012: 12019: 2
2007high 2 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXP

1in 2025

2007: 82008: 102009: 222010: 592011: 312012: 282013: 182014: 192015: 132016: 172017: 162018: 92019: 92020: 312021: 142022: 32023: 22024: 102025: 1
2007high 59 (2010) · low 1 (2025)2025

MAUDE reports naming product code GXP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738708
20080—010
20091—122
20101—059
20110—131
20120—128
20130—018
20140—019
20151—013
20160—017
20171—016
20180—09
20191—29
20200—031
20210—014
20220—03
20232—02
20242—010
20250—01
20264850—

What is it indicated for?

Synthes chronOS is intended for the repair or filling of craniofacial defects and craniotomy cuts with a surface area no larger than 25 cm2. It is also indicated for the restoration or augmentation of bony contours of the craniofacial skeleton, including the fronto-orbital, malar and mental areas.

Synthes chronOS is intended to be gently packed or placed into the site. chronOS resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041350: Synthes (Usa) Chronos.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K041350

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026